Actein
CAS: 18642-44-9
Ref. TM-T7190
1mg | 142.00 € | ||
5mg | 305.00 € | ||
10mg | 460.00 € | ||
25mg | 736.00 € | ||
50mg | 994.00 € | ||
1ml*10 (DMSO) | 408.00 € |
Product Information
- (2S,4aR,5aR,7R,7aR,7bR,8R,12aS,12bS,14aR)-4'-hydroxy-1,1,5',7a,8,12a-hexamethyl-2-(beta-D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate
- (3beta,12beta,16beta,23R,24R,25S,26S))-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cycloanostan-3-yl beta-D-xylopyranoside
- (3β,12β,16β,23R,24R,25S,26S)-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl β-<span class="text-smallcaps">D</span>-xylopyranoside
- 9,19-Cyclolanostane, β-<span class="text-smallcaps">D</span>-xylopyranoside deriv.
- Shengmating
- Spiro[5H-cyclopropa[1′,8′a]naphth[2′,1′:4,5]indeno[2,1-b]pyran-10(2H),2′-[3,6]dioxabicyclo[3.1.0]hexane], β-<span class="text-smallcaps">D</span>-xylopyranoside deriv.
- β-<span class="text-smallcaps">D</span>-Xylopyranoside, (3β,12β,16β,23R,24R,25S,26S)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Actein's ability to pathways involved in lipid disorders and carcinogenesis may make it a new agent for preventing and treating these major disorders, it has been shown to inhibit the proliferation of human breast cancer cells, by altering the activity of the ER IP3 receptor and Na,K-ATPase, inducing calcium release and modulating the NF-kB and MEK pathways.
Chemical properties
Technical inquiry about: TM-T7190 Actein
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.